Oslo, March 6, 2024 -Observe Medical ("the Company" or "Observe Medical") will
release its results for the second half and full year 2023 on Wednesday, 13
March 2024. The presentation will be published on NewsWeb and theCompany's
website at 07:00 CET on the same day.

The Company will host a presentation and Q&Asession at 08:30 CET on the same
day. Personal attendance is welcomed at Olav Vs gate 5, 0161
Oslo (https://www.google.com/maps/place/data=!4m2!3m1!1s0x46416e80b0b4d189:0x542

The session will also be streamed via webcast. To register and follow the
presentation online, please copy and paste the following link into your browser,
click attend and register your e-mail:


After the live event, the presentation and recording will be made availableunder
the Investor Relations section on the Company's website,


For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, Finance Manager Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available atwww.observemedical.com.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange